Abstract:<p>This article is concerned about the test for the difference in the distributions of multigroup proportional data, which is motivated by the problem of comparing the distributions of quality of life (QoL) outcomes among different treatment groups in clinical trials. The proportional data, such as QoL outcomes assessed by answers to questions on a questionnaire, are bounded in a closed interval such as [0,1] with continuous observations in (0,1) and, in addition, excess observations taking the boundary values 0 and/or 1. Common statistical procedures used in practice, such as <i>t</i>‐ and rank‐based tests, may not be very powerful since they ignore the specific feature of the proportional data. In this article, we propose a three‐component mixture model for the proportional data and a density ratio model for the distributions of continuous observations in (0,1). A semiparametric test statistic for the homogeneity of distributions of multigroup proportional data is derived based on the empirical likelihood ratio principle and shown to be asymptotically distributed as a chi‐squared random variable under null hypothesis. A nonparametric bootstrap procedure is proposed to further improve the performance of the semiparametric test. Simulation studies are performed to evaluate the empirical type I error and power of the proposed test procedure and compare it with likelihood ratio tests (LRTs) under parametric distribution assumptions, rank‐based Kruskal‐Wallis test, and Wald‐type test. The proposed test procedure is also applied to the analysis of QoL outcomes from a clinical trial on colorectal cancer that motivated our study.</p>

Homogeneity Tests of Clustered Diagnostic Markers with Applications to the BioCycle Study.

Hybrid Design Evaluating New Biomarkers when There is an Existing Screening Test

Hierarchical Bayesian Clustering Design of Multiple Biomarker Subgroups (HCOMBS)

Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data

Optimal Marker-Adaptive Designs for Targeted Therapy Based on Imperfectly Measured Biomarkers

Bridging Continual Reassessment Method for Phase I Clinical Trials in Different Ethnic Populations

Optimal Marker-Strategy Clinical Trial Design to Detect Predictive Markers for Targeted Therapy

A Design For Survival Studies: A Multi-regional Trial With Unrecognized Heterogeneity

Logistic regression analysis with standardized markers

Homogeneity tests and interval estimations of risk differences for stratified bilateral and unilateral correlated data

Comparison of Diagnostic Markers with Repeated Measurements: a Non-Parametric ROC Curve Approach.

Assessing heterogeneity in surrogacy using censored data

Comparison of tests for categorical data from a stratified cluster randomized trial

A bootstrap semiparametric homogeneity test for the distributions of multigroup proportional data, with applications to analysis of quality of life outcomes in clinical trials

Different view of the diagnostics test accuracy measures and optimal cut-off point selection procedure under tree or umbrella ordering

Nonparametric ROC Summary Statistics for Correlated Diagnostic Marker Data

Statistical Methods for Selective Biomarker Testing

Issues and solutions in biomarker evaluation when subclasses are involved under binary classification

A Dunnett-Type Test and Its Sample Size Calculation for Comparing K ROC Curves with a Control

Testing homogeneity of proportions from sparse binomial data with a large number of groups

Nonparametric Biomarker Based Treatment Selection With Reproducibility Data